Click for best price
TCell Immunotherapy Market Size, Share 2024
This research report provides a comprehensive analysis of the T-Cell Immunotherapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global T-Cell Immunotherapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of T-Cell Immunotherapy, challenges faced by the industry, and potential opportunities for market players.
The global T-Cell Immunotherapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The T-Cell Immunotherapy market presents opportunities for various stakeholders, including Stomach Cancer, Lung Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in T-Cell Immunotherapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global T-Cell Immunotherapy market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the T-Cell Immunotherapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the T-Cell Immunotherapy market.
Market Overview: The report provides a comprehensive overview of the T-Cell Immunotherapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., CAR-T, TCR), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the T-Cell Immunotherapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the T-Cell Immunotherapy market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the T-Cell Immunotherapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the T-Cell Immunotherapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the T-Cell Immunotherapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the T-Cell Immunotherapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for T-Cell Immunotherapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the T-Cell Immunotherapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
T-Cell Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
CAR-T
TCR
TIL Therapies
Market segment by Application
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
Global T-Cell Immunotherapy Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of T-Cell Immunotherapy, market overview.
Chapter 2: Global T-Cell Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of T-Cell Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of T-Cell Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
T-Cell Immunotherapy Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
93 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 T-Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-Cell Immunotherapy Overall Market Size
2.1 Global T-Cell Immunotherapy Market Size: 2023 VS 2030
2.2 Global T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T-Cell Immunotherapy Players in Global Market
3.2 Top Global T-Cell Immunotherapy Companies Ranked by Revenue
3.3 Global T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 T-Cell Immunotherapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-Cell Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 T-Cell Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global T-Cell Immunotherapy Market Size Markets, 2023 & 2030
4.1.2 CAR-T
4.1.3 TCR
4.1.4 TIL Therapies
4.2 By Type - Global T-Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global T-Cell Immunotherapy Revenue, 2019-2024
4.2.2 By Type - Global T-Cell Immunotherapy Revenue, 2025-2030
4.2.3 By Type - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T-Cell Immunotherapy Market Size, 2023 & 2030
5.1.2 Stomach Cancer
5.1.3 Lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Esophagus Cancer
5.1.6 Pancreatic Cancer
5.1.7 Others
5.2 By Application - Global T-Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global T-Cell Immunotherapy Revenue, 2019-2024
5.2.2 By Application - Global T-Cell Immunotherapy Revenue, 2025-2030
5.2.3 By Application - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global T-Cell Immunotherapy Market Size, 2023 & 2030
6.2 By Region - Global T-Cell Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global T-Cell Immunotherapy Revenue, 2019-2024
6.2.2 By Region - Global T-Cell Immunotherapy Revenue, 2025-2030
6.2.3 By Region - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America T-Cell Immunotherapy Revenue, 2019-2030
6.3.2 US T-Cell Immunotherapy Market Size, 2019-2030
6.3.3 Canada T-Cell Immunotherapy Market Size, 2019-2030
6.3.4 Mexico T-Cell Immunotherapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe T-Cell Immunotherapy Revenue, 2019-2030
6.4.2 Germany T-Cell Immunotherapy Market Size, 2019-2030
6.4.3 France T-Cell Immunotherapy Market Size, 2019-2030
6.4.4 U.K. T-Cell Immunotherapy Market Size, 2019-2030
6.4.5 Italy T-Cell Immunotherapy Market Size, 2019-2030
6.4.6 Russia T-Cell Immunotherapy Market Size, 2019-2030
6.4.7 Nordic Countries T-Cell Immunotherapy Market Size, 2019-2030
6.4.8 Benelux T-Cell Immunotherapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia T-Cell Immunotherapy Revenue, 2019-2030
6.5.2 China T-Cell Immunotherapy Market Size, 2019-2030
6.5.3 Japan T-Cell Immunotherapy Market Size, 2019-2030
6.5.4 South Korea T-Cell Immunotherapy Market Size, 2019-2030
6.5.5 Southeast Asia T-Cell Immunotherapy Market Size, 2019-2030
6.5.6 India T-Cell Immunotherapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America T-Cell Immunotherapy Revenue, 2019-2030
6.6.2 Brazil T-Cell Immunotherapy Market Size, 2019-2030
6.6.3 Argentina T-Cell Immunotherapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa T-Cell Immunotherapy Revenue, 2019-2030
6.7.2 Turkey T-Cell Immunotherapy Market Size, 2019-2030
6.7.3 Israel T-Cell Immunotherapy Market Size, 2019-2030
6.7.4 Saudi Arabia T-Cell Immunotherapy Market Size, 2019-2030
6.7.5 UAE T-Cell Immunotherapy Market Size, 2019-2030
7 T-Cell Immunotherapy Companies Profiles
7.1 Adaptimmune
7.1.1 Adaptimmune Company Summary
7.1.2 Adaptimmune Business Overview
7.1.3 Adaptimmune T-Cell Immunotherapy Major Product Offerings
7.1.4 Adaptimmune T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.1.5 Adaptimmune Key News & Latest Developments
7.2 Altor Bioscience Corporation
7.2.1 Altor Bioscience Corporation Company Summary
7.2.2 Altor Bioscience Corporation Business Overview
7.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Major Product Offerings
7.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.2.5 Altor Bioscience Corporation Key News & Latest Developments
7.3 Cellectis
7.3.1 Cellectis Company Summary
7.3.2 Cellectis Business Overview
7.3.3 Cellectis T-Cell Immunotherapy Major Product Offerings
7.3.4 Cellectis T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.3.5 Cellectis Key News & Latest Developments
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Company Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics T-Cell Immunotherapy Major Product Offerings
7.4.4 Juno Therapeutics T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.4.5 Juno Therapeutics Key News & Latest Developments
7.5 Kite Pharma
7.5.1 Kite Pharma Company Summary
7.5.2 Kite Pharma Business Overview
7.5.3 Kite Pharma T-Cell Immunotherapy Major Product Offerings
7.5.4 Kite Pharma T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.5.5 Kite Pharma Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis T-Cell Immunotherapy Major Product Offerings
7.6.4 Novartis T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.6.5 Novartis Key News & Latest Developments
7.7 Takara Bio
7.7.1 Takara Bio Company Summary
7.7.2 Takara Bio Business Overview
7.7.3 Takara Bio T-Cell Immunotherapy Major Product Offerings
7.7.4 Takara Bio T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.7.5 Takara Bio Key News & Latest Developments
7.8 Unum Therapeutics
7.8.1 Unum Therapeutics Company Summary
7.8.2 Unum Therapeutics Business Overview
7.8.3 Unum Therapeutics T-Cell Immunotherapy Major Product Offerings
7.8.4 Unum Therapeutics T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.8.5 Unum Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. T-Cell Immunotherapy Market Opportunities & Trends in Global Market
Table 2. T-Cell Immunotherapy Market Drivers in Global Market
Table 3. T-Cell Immunotherapy Market Restraints in Global Market
Table 4. Key Players of T-Cell Immunotherapy in Global Market
Table 5. Top T-Cell Immunotherapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global T-Cell Immunotherapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies T-Cell Immunotherapy Product Type
Table 9. List of Global Tier 1 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global T-Cell Immunotherapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global T-Cell Immunotherapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 30. Adaptimmune Company Summary
Table 31. Adaptimmune T-Cell Immunotherapy Product Offerings
Table 32. Adaptimmune T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 33. Adaptimmune Key News & Latest Developments
Table 34. Altor Bioscience Corporation Company Summary
Table 35. Altor Bioscience Corporation T-Cell Immunotherapy Product Offerings
Table 36. Altor Bioscience Corporation T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 37. Altor Bioscience Corporation Key News & Latest Developments
Table 38. Cellectis Company Summary
Table 39. Cellectis T-Cell Immunotherapy Product Offerings
Table 40. Cellectis T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 41. Cellectis Key News & Latest Developments
Table 42. Juno Therapeutics Company Summary
Table 43. Juno Therapeutics T-Cell Immunotherapy Product Offerings
Table 44. Juno Therapeutics T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 45. Juno Therapeutics Key News & Latest Developments
Table 46. Kite Pharma Company Summary
Table 47. Kite Pharma T-Cell Immunotherapy Product Offerings
Table 48. Kite Pharma T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 49. Kite Pharma Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis T-Cell Immunotherapy Product Offerings
Table 52. Novartis T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 53. Novartis Key News & Latest Developments
Table 54. Takara Bio Company Summary
Table 55. Takara Bio T-Cell Immunotherapy Product Offerings
Table 56. Takara Bio T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 57. Takara Bio Key News & Latest Developments
Table 58. Unum Therapeutics Company Summary
Table 59. Unum Therapeutics T-Cell Immunotherapy Product Offerings
Table 60. Unum Therapeutics T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 61. Unum Therapeutics Key News & Latest Developments
List of Figures
Figure 1. T-Cell Immunotherapy Segment by Type in 2023
Figure 2. T-Cell Immunotherapy Segment by Application in 2023
Figure 3. Global T-Cell Immunotherapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global T-Cell Immunotherapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global T-Cell Immunotherapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2023
Figure 8. By Type - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 16. US T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 20. Germany T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 21. France T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 28. China T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 32. India T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 34. Brazil T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 37. Turkey T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 41. Adaptimmune T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Altor Bioscience Corporation T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Cellectis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Juno Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Kite Pharma T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Novartis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Takara Bio T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Unum Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
